Investors Applaud Merck’s Decision to Share Children’s HIV/AIDS Patent
27 February 2015
Faith-based investors say move will make Raltegravir accessible and affordable for millions of vulnerable children
Faith-based investors say move will make Raltegravir accessible and affordable for millions of vulnerable children